Home
>
National Drug Code (NDC)
>
Gliadel
Gliadel - 62856-177-08 - (polifeprosan 20 with carmustine implant)
Drug Information of Gliadel
| Product NDC: | 62856-177 |
| Proprietary Name: | Gliadel |
| Non Proprietary Name: | polifeprosan 20 with carmustine implant |
| Active Ingredient(s): | 7.7 mg/1 & nbsp; polifeprosan 20 with carmustine implant |
| Administration Route(s): | INTRACAVITARY |
| Dosage Form(s): | WAFER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Gliadel
| Product NDC: | 62856-177 |
| Labeler Name: | Eisai Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020637 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960924 |
Package Information of Gliadel
| Package NDC: | 62856-177-08 |
| Package Description: | 8 POUCH in 1 BOX (62856-177-08) > 1 WAFER in 1 POUCH |
NDC Information of Gliadel
| NDC Code | 62856-177-08 |
| Proprietary Name | Gliadel |
| Package Description | 8 POUCH in 1 BOX (62856-177-08) > 1 WAFER in 1 POUCH |
| Product NDC | 62856-177 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | polifeprosan 20 with carmustine implant |
| Dosage Form Name | WAFER |
| Route Name | INTRACAVITARY |
| Start Marketing Date | 19960924 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai Inc. |
| Substance Name | CARMUSTINE |
| Strength Number | 7.7 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
